Published time:14 May 2020
Authors: Neo Poyiadji, Peter Cormier, Parth Y. Patel, Mohamad O. Hadied, Pallavi Bhargava, Kanika Khanna, Jeffrey Nadig, Thomas Keimig, David Spizarny, Nicholas Reeser, Chad Klochko, Edward L. Peterson, Thomas Son
Keywords: Thrombotic complications, Covid-19, Pulmonary embolism, ishemic stroke, mortality.
Thrombotic complications in patients diagnosed with COVID-19 are emerging as important sequelae that contribute to significant morbidity and mortality. Pulmonary embolism (PE), deep vein thrombosis, ischemic stroke and myocardial infarction are examples of complications described in patients with increasing frequency. Recent publications propose excessive inflammation, hypoxia, immobilization and diffuse intravascular coagulation in the setting of COVID-19 infection as contributors to a prothrombotic state. The purpose of this study was to evaluate the clinical characteristics of COVID-19 patients that developed pulmonary embolism and compare their inflammatory markers, D-dimer values and outcomes.
Acute Pulmonary Embolism and COVID-19